CDT Equity Inc.
CDTNasdaqCIK 1896212HealthcareFiscal year ends Dec 31
Reports and events: 134 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-07-3119:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-021793 |
| 2025-07-0812:04 ET | DEF 14A | Proxy statementPeriod 2025-07-08 | 0001641172-25-018242 |
| 2025-06-0916:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014322 |
| 2025-06-0316:30 ET | 8-K | 5.08 Item not in the standard list | 0001641172-25-013468 |
| 2025-05-1608:45 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011183 |
| 2025-05-1519:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010405 |
| 2025-05-0616:30 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-008854 |
| 2025-04-2517:00 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001641172-25-006259 |
| 2025-04-2516:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006224 |
| 2025-04-1616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005036 |
| 2025-04-0416:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001641172-25-002774 |
| 2025-04-0216:34 ET | 8-K/A | 8.01 Other events | 0001641172-25-002400 |
| 2025-04-0117:23 ET | 8-K | 8.01 Other events | 0001641172-25-002147 |
| 2025-03-2816:54 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001246 |
| 2025-03-0608:30 ET | 8-K | 8.01 Other events | 0001493152-25-009330 |
| 2025-02-1916:15 ET | 8-K | 1.02 Termination of a material agreement; 3.01 Delisting notice; 8.01 Other events | 0001493152-25-007573 |
| 2025-02-1108:00 ET | 8-K | 8.01 Other events | 0001493152-25-005796 |
| 2025-01-2308:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-003316 |
| 2025-01-1416:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-002176 |
| 2024-12-2017:00 ET | 8-K | 3.01 Delisting notice; 5.07 Shareholder vote results | 0001493152-24-051089 |
| 2024-12-1717:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-050443 |
| 2024-12-0608:30 ET | DEF 14A | Proxy statementPeriod 2024-12-06 | 0001493152-24-049097 |
| 2024-11-2516:53 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-047631 |
| 2024-11-1917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-046849 |
| 2024-11-1417:27 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-046088 |
| 2024-11-1417:24 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-06-30 | 0001493152-24-046080 |
| 2024-11-1417:22 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001493152-24-046074 |
| 2024-11-1417:20 ET | 8-K | 4.02 Non-reliance on financial statements | 0001493152-24-046068 |
| 2024-11-0116:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-043330 |
| 2024-10-2817:15 ET | DEF 14A | Proxy statementPeriod 2024-10-28 | 0001493152-24-042718 |
| 2024-10-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-041154 |
| 2024-09-1916:59 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-037144 |
| 2024-09-1316:05 ET | S-1/A | Registration statement, amended | 0001493152-24-036199 |
| 2024-09-0617:00 ET | 8-K | 5.08 Item not in the standard list | 0001493152-24-035334 |
| 2024-09-0416:44 ET | S-1 | Registration statement | 0001493152-24-034991 |
| 2024-08-1616:59 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001493152-24-032854 |
| 2024-08-1217:29 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031385 |
| 2024-08-0808:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-030681 |
| 2024-08-0717:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-030568 |
| 2024-07-1116:15 ET | 8-K/A | 5.08 Item not in the standard list | 0001493152-24-026957 |
| 2024-07-0116:30 ET | 8-K | 5.08 Item not in the standard list | 0001493152-24-025805 |
| 2024-05-3117:00 ET | 8-K | 3.01 Delisting notice | 0001493152-24-022228 |
| 2024-05-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019230 |
| 2024-04-1617:29 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-014889 |
| 2024-04-1617:27 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-24-014883 |
| 2023-12-0116:50 ET | S-1/A | Registration statement, amended | 0001493152-23-043429 |
| 2023-11-2120:37 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-09-30 | 0001493152-23-042184 |
| 2023-11-2017:29 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-042176 |
| 2023-10-1716:49 ET | S-1 | Registration statement | 0001493152-23-037514 |
| 2023-10-0517:25 ET | 8-K/A | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-036388 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:50 ET. Listed shows no prices and gives no investment advice.